BNL Reports

15 Stocks to Double In 2017: FEYE, GM, CHK, MRO, & SRPT Stock

If FireEye, General Motors, Chesapeake, Marathon, and Sarepta manage risks, then FEYE, GM, CHK, MRO, & SRPT stock will double in 2017.

Also posted in Hot Stocks, Members | | Tagged , , , , , , , , , | Leave a comment

15 Stocks to Double In 2017: FIT, XPO, SKX, VRX, GNC

If Fitbit, XPO Logistics, Skechers, Valeant, and GNC solve a few problems, then FIT stock, XPO stock, SKX stock, and VRX stock could all double.

Also posted in Hot Stocks, Members | | Tagged , , , , , , , , | Leave a comment

15 Stocks to Double In 2017: TWTR, LC, FNMA, FMCC, SBGL

TWTR, LC stock, SBGL, FNMA stock, and FMCC stock are among the 15 stocks that could double in 2017, but will it actually happen for any of them?

Also posted in Hot Stocks, Members | | Tagged , , , , , , , , , | 3 Comments

5 Laggards That Are Bargains In 2017: Fitbit, Mylan, JAZZ, RH, & DPLO

Fitbit (FIT), Mylan (MYL), Jazz Pharmaceuticals (JAZZ), Diplomat Pharmacy (DPLO), and RH are all 2016 stock laggards that will likely soar this year.

Also posted in Members, Portfolio Strategy, Timely Analysis | | Tagged , , , , , , , , | Leave a comment

Acadia Pharmaceuticals Inc (ACAD) Outlook With Lewy Body Dementia & Off Label Nuplazid Use

Acadia Pharmaceuticals’ Nuplazid is reportedly seeing a rise in off label use, specifically With Lewy Body Dementia. That’s great news for ACAD stock.

Also posted in Healthcare & Biotech | | Tagged , | 3 Comments

10 Acquisition Predictions For 2017: FIT, TWTR, ACAD, SKX, DISH

A series that examines 10 acquisition targets in 2017. Furthermore, we identify the companies most likely to acquire FIT, TWTR, ACAD, SKX, & DISH

Also posted in Members, Mergers & Acquisitions | | Tagged , , , , , , , , , | Leave a comment

BNL Portfolio Strategy For 2017

Diversified portfolio strategy that includes lots of cash, bonds, SKX, VRX, FIT, GPRO, and other stocks to beat the market.

Also posted in 2017 Stock Outlook, Build My Portfolio, Members | | Tagged , , , , , , , | Leave a comment